Pharma & Biotech

The stock of biotechnology firm Ocugen has experienced a significant rally, propelled by a combination of promising clinical developments for...

Pharmaceutical leader Eli Lilly continues to solidify its position in the weight-loss medication sector. The company is benefiting from a...

Investors in Spero Therapeutics are closely monitoring the coming weeks, which could prove pivotal for the company’s fight against multidrug-resistant...

A notable shift is occurring within the shareholder base of medical technology firm Fractyl Health. Specialized investment firms are accumulating...

As mid-March 2026 approaches, Reflect Scientific enters a pivotal period. The company faces the essential challenge of demonstrating it can...

Pfizer's ambitious portfolio transformation is beginning to yield tangible results. A significant milestone was achieved with the recent regulatory approval...

Major investment firms are building significant positions in Danaher Corporation, signaling confidence in the life sciences and diagnostics specialist despite...

As March 2026 unfolds, Innoviva continues to solidify its standing within the specialized healthcare market. Investor attention is pivoting toward...

Sangamo Therapeutics is advancing decisively with its investigational gene therapy, ST-920, for Fabry disease. The company has submitted critical data...

Anixa Biosciences continues to advance its oncology pipeline, supported by encouraging clinical data and a shareholder-endorsed management team. Recent developments...